Ulcerative Colitis
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding.
Ulcerative Colitis: GS-5290 Medication Study
We are testing a new medication for people with moderately to severely active ulcerative colitis to see if it helps improve symptoms better than a placebo. The study will assess various measures of clinical response and remission.
1-2 years11-15 visitsEfficacy phase (II)Cost ReimbursementInvestigational MedicinesOralGastroenterologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Are you assigned male at birth, or assigned female at birth and not pregnant or breastfeeding?
- Do you have ulcerative colitis (UC) that has lasted at least 90 days?
- Have you had any significant infections that required hospitalization or intravenous treatment in the last 8 weeks?
- Do you have a current diagnosis of Crohn's disease or indeterminate colitis?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Gs-5290
Phosphonooxy methyln
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medizinische Universitaet Innsbruck
University Hospital for Internal Medicine I-Gastroenterology,Endocrinology,Metabolism and Hepatology
Innsbruck, Austria
Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH
University Clinic for Internal Medicine I
Salzburg, Austria
Noe LGA Gesundheit Region Mitte GmbH
Division of Internal Medicine II
Sankt Pölten, Austria
Sponsor: Gilead Sciences Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.